Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cholesterol affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritis.
Cancer drug shows promise for multiple sclerosis.
Leukocyte counts in cerebrospinal fluid and blood following firategrast treatment in subjects with relapsing forms of multiple sclerosis.
The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?
Targeting thalamic tremor cells in deep brain stimulation for multiple sclerosis-induced complex tremor.
Association of interleukin (IL)-4 gene intron 3 VNTR polymorphism with multiple sclerosis in Turkish population.
Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.
Effects of vaccination with altered Peptide ligand on chronic pain in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
Is serum vitamin D levels associated with disability in patients with newly diagnosed multiple sclerosis?
Evaluation of the Persian version of modified fatigue impact scale in Iranian patients with multiple sclerosis.
[Acute disseminated encephalomyelitis is an important differential diagnosis in the acutely affected child].
[Plasmapheresis in acute phase of multiple sclerosis].
microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases.
Verbal Fluencies and Fampridine Treatment in Multiple Sclerosis.
Remyelination Therapy in Multiple Sclerosis.
Mechanisms of remyelination: recent insight from experimental models.
Endocannabinoid signalling and the deteriorating brain.
A single-nucleotide polymorphism in serine-threonine kinase 11, the gene encoding liver kinase b1, is a risk factor for multiple sclerosis.
Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica.
Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases.
Muscular dystrophy in a patient with multiple sclerosis. Another "double-trouble"?
Sexuality and multiple sclerosis.
Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis optica.
[The cost-effectiveness of interferon beta treatment in patients with a clinically isolated syndrome in Colombia].
Understanding the pharmacology of stroke and multiple sclerosis through imaging.
Pages
« first
‹ previous
…
603
604
605
606
607
608
609
610
611
…
next ›
last »